Cigna Investments’s Ingredion INGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-2,362
Closed -$212K – 761
2021
Q1
$212K Buy
+2,362
New +$202K 0.01% 724
2020
Q3
– Sell
-3,375
Closed -$280K – 696
2020
Q2
$280K Buy
+3,375
New +$276K 0.03% 568
2019
Q1
– Sell
-2,199
Closed -$201K – 730
2018
Q4
$201K Buy
2,199
+49
+2% +$4.9K 0.02% 675
2018
Q3
$217K Sell
2,150
-208
-9% -$21.2K 0.02% 668
2018
Q2
$260K Sell
2,358
-400
-15% -$47K 0.02% 628
2018
Q1
$355K Hold
2,758
– – 0.02% 580
2017
Q4
$385K Sell
2,758
-2,597
-48% -$343K 0.03% 590
2017
Q3
$645K Sell
5,355
-5,694
-52% -$694K 0.04% 364
2017
Q2
$1.32M Sell
11,049
-2,601
-19% -$309K 0.09% 184
2017
Q1
$1.65M Buy
13,650
+324
+2% +$39.6K 0.11% 145
2016
Q4
$1.67M Buy
+13,326
New +$1.68M 0.18% 124

Other funds holding INGR

Cigna Investments's INGR Position: Q2 2021 in Review

Cigna Investments sold out of Ingredion (INGR) in Q2 2021, closing a stake of 2,362 shares — an estimated $212K sold.

Cigna Investments first reported a position in INGR in Q4 2016 and held it in 11 quarters. The position peaked at $1.67M in Q4 2016. 435 funds tracked by Wall St. Rank hold INGR as of Q2 2021.

  • Cigna Investments reported no remaining Ingredion position as of Q2 2021 after selling out during the quarter.
  • Cigna Investments sold 2,362 Ingredion shares in Q2 2021, an estimated $212K.
  • Cigna Investments first reported a position in Ingredion in Q4 2016 and held it in 11 quarters.
  • Cigna Investments's Ingredion position peaked at $1.67M in Q4 2016.
  • 435 funds tracked by Wall St. Rank held Ingredion as of Q2 2021.

Based on Cigna Investments's 13F filing for Q2 2021, filed 10 Aug 2021.